METRONIDAZOLE INDUCED REVERSIBLE CEREBELLAR TOXICITY A CASE REPORT OF UNCOMMON SIDE EFFECTS OF COMMONLY USED DRUG

METRONIDAZOLE INDUCED REVERSIBLE CEREBELLAR TOXICITY A CASE REPORT OF UNCOMMON SIDE EFFECTS OF COMMONLY USED DRUG

Institutions

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2024-08-04
DOI
https://doi.org/10.5281/zenodo.13208076
Primary Topic
Employer Branding and e-HRM
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

METRONIDAZOLE INDUCED REVERSIBLE CEREBELLAR TOXICITY A CASE REPORT OF UNCOMMON SIDE EFFECTS OF COMMONLY USED DRUG

Zenodo (CERN European Organization for Nuclear Research)
Employer Branding and e-HRM
article

METRONIDAZOLE INDUCED REVERSIBLE CEREBELLAR TOXICITY A CASE REPORT OF UNCOMMON SIDE EFFECTS OF COMMONLY USED DRUG

article en

Abstract

METRONIDAZOLE INDUCED REVERSIBLE CEREBELLAR TOXICITY A CASE REPORT OF UNCOMMON SIDE EFFECTS OF COMMONLY USED DRUG

Zenodo (CERN European Organization for Nuclear Research)
B.J. Medical College (IN)
Good health and well-being
Openalex Percentile: Top 47%
Employer Branding and e-HRM
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

METRONIDAZOLE INDUCED REVERSIBLE CEREBELLAR TOXICITY A CASE REPORT OF UNCOMMON SIDE EFFECTS OF COMMONLY USED DRUG · Zenodo (CERN European Organization for Nuclear Research) (2024) | TGRS Research Map | TGRS